Anti-LCN12 functional antibody

Anti-LCN12 functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to LCN12/LCN12 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE1060-Ab-1/ GM-Tg-hg-SE1060-Ab-2Anti-Human LCN12 monoclonal antibodyHuman
GM-Tg-rg-SE1060-Ab-1/ GM-Tg-rg-SE1060-Ab-2Anti-Rat LCN12 monoclonal antibodyRat
GM-Tg-mg-SE1060-Ab-1/ GM-Tg-mg-SE1060-Ab-2Anti-Mouse LCN12 monoclonal antibodyMouse
GM-Tg-cynog-SE1060-Ab-1/ GM-Tg-cynog-SE1060-Ab-2Anti-Cynomolgus/ Rhesus macaque LCN12 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE1060-Ab-1/ GM-Tg-felg-SE1060-Ab-2Anti-Feline LCN12 monoclonal antibodyFeline
GM-Tg-cang-SE1060-Ab-1/ GM-Tg-cang-SE1060-Ab-2Anti-Canine LCN12 monoclonal antibodyCanine
GM-Tg-bovg-SE1060-Ab-1/ GM-Tg-bovg-SE1060-Ab-2Anti-Bovine LCN12 monoclonal antibodyBovine
GM-Tg-equg-SE1060-Ab-1/ GM-Tg-equg-SE1060-Ab-2Anti-Equine LCN12 monoclonal antibodyEquine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE1060-Ab-1/ GM-Tg-hg-SE1060-Ab-2; GM-Tg-rg-SE1060-Ab-1/ GM-Tg-rg-SE1060-Ab-2;
GM-Tg-mg-SE1060-Ab-1/ GM-Tg-mg-SE1060-Ab-2; GM-Tg-cynog-SE1060-Ab-1/ GM-Tg-cynog-SE1060-Ab-2;
GM-Tg-felg-SE1060-Ab-1/ GM-Tg-felg-SE1060-Ab-2; GM-Tg-cang-SE1060-Ab-1/ GM-Tg-cang-SE1060-Ab-2;
GM-Tg-bovg-SE1060-Ab-1/ GM-Tg-bovg-SE1060-Ab-2; GM-Tg-equg-SE1060-Ab-1/ GM-Tg-equg-SE1060-Ab-2
Products NameAnti-LCN12 monoclonal antibody
Formatmab
Target NameLCN12
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)		IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-LCN12 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE1060-Ag-1Recombinant multi-species LCN12 protein


    Target information

    Target IDGM-SE1060
    Target NameLCN12
    Gene ID286256,77701,680602,708099,491242,101099088,789434,100067967
    Gene Symbol and Synonyms9230102M18Rik,LCN12
    Uniprot AccessionQ6JVE5,B3EY83
    Uniprot Entry NameLCN12_HUMAN,LCN12_RAT
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000184925
    Target ClassificationN/A

    The target: LCN12, gene name: LCN12, also named as . Members of the lipocalin family, such as LCN12, have a common structure consisting of an 8-stranded antiparallel beta-barrel that forms a cup-shaped ligand-binding pocket or calyx. Lipocalins generally bind small hydrophobic ligands and transport them to specific cells (Suzuki et al., 2004 [PubMed 15363845]).[supplied by OMIM, Aug 2009].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.